Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil Benedek

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Science Translational Medicine|February 23, 2021
Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR testsNetta Barak, Roni Ben-Ami, Tal Sido, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
MIF and D-DT are potential disease severity modifiers in male MS subjectsGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Plos One|November 14, 2024
Correction: Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis bufferOran Erster, Omer Shkedi, Gil Benedek, et al.
Plos One|March 30, 2021
Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis bufferOran Erster, Omer Shkedi, Gil Benedek, et al.
Cell Reports. Medicine|December 17, 2025
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentationShira Sagie, Tomer Babu, Chen Weller, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Cancer Discovery|October 7, 2025
Recurrent immunogenic neoantigens and their cognate T-cell receptors in treatment-resistant metastatic prostate cancerNofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, et al.
Cancer Cell|March 28, 2025
Translation dysregulation in cancer as a source for targetable antigensChen Weller, Osnat Bartok, Christopher S McGinnis, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Science Translational Medicine|February 23, 2021
Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR testsNetta Barak, Roni Ben-Ami, Tal Sido, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2017
MIF and D-DT are potential disease severity modifiers in male MS subjectsGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Plos One|November 14, 2024
Correction: Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis bufferOran Erster, Omer Shkedi, Gil Benedek, et al.
Plos One|March 30, 2021
Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis bufferOran Erster, Omer Shkedi, Gil Benedek, et al.
Cell Reports. Medicine|December 17, 2025
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentationShira Sagie, Tomer Babu, Chen Weller, et al.
The Journal of Clinical Investigation|October 15, 2021
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanomaAviyah Peri, Erez Greenstein, Michal Alon, et al.
Cancer Discovery|October 7, 2025
Recurrent immunogenic neoantigens and their cognate T-cell receptors in treatment-resistant metastatic prostate cancerNofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, et al.
Cancer Cell|March 28, 2025
Translation dysregulation in cancer as a source for targetable antigensChen Weller, Osnat Bartok, Christopher S McGinnis, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
Pageof 4